Two Sigma Advisers
KYMR icon

Two Sigma Advisers’s Kymera Therapeutics KYMR Stock Holding History

Two Sigma Advisers’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-373,800
Closed -$29.1M – 1153
2025
Q4 		$29.1M Buy
373,800
+1,400
+0.4% +$94.5K 0.06% 266
2025
Q3 		$21.1M Buy
372,400
+148,100
+66% +$6.68M 0.04% 318
2025
Q2 		$9.79M Buy
224,300
+41,000
+22% +$1.41M 0.02% 509
2025
Q1 		$5.02M Sell
183,300
-77,000
-30% -$2.81M 0.01% 791
2024
Q4 		$10.5M Sell
260,300
-76,000
-23% -$3.43M 0.02% 473
2024
Q3 		$15.9M Sell
336,300
-30,700
-8% -$1.36M 0.04% 368
2024
Q2 		$11M Buy
367,000
+157,900
+76% +$5.47M 0.02% 512
2024
Q1 		$8.41M Buy
209,100
+38,200
+22% +$1.37M 0.02% 590
2023
Q4 		$4.35M Sell
170,900
-17,600
-9% -$315K 0.01% 876
2023
Q3 		$2.62M Buy
188,500
+25,900
+16% +$521K 0.01% 1051
2023
Q2 		$3.74M Sell
162,600
-39,500
-20% -$1.13M 0.01% 890
2023
Q1 		$5.99M Buy
202,100
+18,800
+10% +$606K 0.02% 738
2022
Q4 		$4.58M Buy
183,300
+5,300
+3% +$141K 0.01% 820
2022
Q3 		$3.88M Sell
178,000
-53,700
-23% -$1.42M 0.01% 868
2022
Q2 		$4.56M Buy
231,700
+204,900
+765% +$4.79M 0.01% 816
2022
Q1 		$1.13M Buy
26,800
+21,400
+396% +$904K ﹤0.01% 1575
2021
Q4 		$343K Buy
+5,400
New +$315K ﹤0.01% 2091

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Two Sigma Advisers's KYMR Position: Q1 2026 in Review

Two Sigma Advisers sold out of Kymera Therapeutics (KYMR) in Q1 2026, closing a stake of 373,800 shares — an estimated $29.1M sold.

Two Sigma Advisers first reported a position in KYMR in Q4 2021 and held it in 17 quarters. The position peaked at $29.1M in Q4 2025. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • Two Sigma Advisers reported no remaining Kymera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 373,800 Kymera Therapeutics shares in Q1 2026, an estimated $29.1M.
  • Two Sigma Advisers first reported a position in Kymera Therapeutics in Q4 2021 and held it in 17 quarters.
  • Two Sigma Advisers's Kymera Therapeutics position peaked at $29.1M in Q4 2025.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.